Contact
searchSearch
HMP Global

Atopic Dermatitis Topic Center

Featured

atopic dermatitis
FDA Alerts
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.15% for Treatment of Atopic Dermatitis in Adults and Children Aged 6 and Older
07/09/2024
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug...
07/09/2024
The Dermatologist
psoriasis
News
PF-07038124 in Treating Atopic Dermatitis and Plaque Psoriasis
06/24/2024
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist
eczema
News
Novel Efficacy Index Compares Long-Term Therapy Outcomes in Atopic Dermatitis Treatments
06/22/2024
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess...
06/22/2024
The Dermatologist
Atopic dermatitis
News
Improving Biomarkers in Atopic Dermatitis: Insights from Lebrikizumab Studies
06/21/2024
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the...
06/21/2024
The Dermatologist
Atopic dermatitis
News
Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients Age ≥60 Years
06/20/2024
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist
AD
News
Ruxolitinib Cream for Patients With Facial and/or Neck Atopic Dermatitis
06/19/2024
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at...
06/19/2024
The Dermatologist
social media
News
Real-world Insights: Physician-assessed and Patient-reported Outcomes in Atopic Dermatitis Patients Treated with Dupilumab
06/16/2024
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the...
06/16/2024
The Dermatologist
AD
FDA Alerts
FDA Approves Tralokinumab Autoinjector for Adults with Moderate-to-Severe Atopic Dermatitis
06/15/2024
The US Food and Drug Administration has approved a new Adbry (tralokinumab-ldrm) 300 mg single-dose autoinjector, offering a new administration option for adult patients with moderate-to-severe atopic dermatitis.
The US Food and Drug Administration has approved a new Adbry (tralokinumab-ldrm) 300 mg single-dose autoinjector, offering a new administration option for adult patients with moderate-to-severe atopic dermatitis.
The US Food and Drug...
06/15/2024
The Dermatologist
AD
News
Efficacy of Targeted Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis
06/15/2024
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in...
06/15/2024
The Dermatologist
medical bill
News
Identifying Candidates for Systemic Therapy in Atopic Dermatitis: A Practical Checklist
06/14/2024
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the,...
06/14/2024
The Dermatologist

Multimedia

Fall Clinical AD Roundtable
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following Fall Clinical
11/03/2022
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs...
11/03/2022
The Dermatologist
Roundtable AAD
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAD
08/15/2022
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
Drs Friedman, Lio, Shi and Kirkorian
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAAAI
07/15/2022
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs...
07/15/2022
The Dermatologist
Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Shawn Kwatra, MD
Videos
ICYM RAD 2022: Dr Kwatra on Itch in Atopic Dermatitis
04/13/2022
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual...
04/13/2022
The Dermatologist
James Song
Videos
JAK Inhibitors in Treating Atopic Dermatitis
12/02/2024
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song...
12/02/2024
The Dermatologist
Gil Yosipovitch, MD,
Videos
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
The Dermatologist
Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 6, Combatting Barriers to Care For Elder Patients
10/16/2024
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
Sadick
Videos
Innovations in Regenerative Medicine
09/12/2024
In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...
In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...
In this interview, Dr Sadick...
09/12/2024
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
06/21/2024
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
06/21/2024
The Dermatologist
Ramone F. Williams, MD, MPhil
Videos
Mohs Surgeons Leading the Future: Advancing Careers and Care
06/14/2024

Featuring Ramone F. Williams, MD, MPhil

Featuring Ramone F. Williams, MD, MPh...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F....
06/14/2024
The Dermatologist
SPONSORED VIDEO
Hear From the Experts: The Importance of Multidisciplinary Care in Advanced BCC and Advanced CSCC
05/22/2024
In collaboration with Regeneron’s Let’s Get Real About Skin Cancer program, a panel of distinguished dermatologists and oncologists delve into the critical importance of a multidisciplinary care team (MDT) for advanced cases of non-melanoma...
In collaboration with Regeneron’s Let’s Get Real About Skin Cancer program, a panel of distinguished dermatologists and oncologists delve into the critical importance of a multidisciplinary care team (MDT) for advanced cases of non-melanoma...
In collaboration with...
05/22/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
The ElderDerm: Episode 3, Shared-Decision Making
05/16/2024

Featuring Dr Adam Friedman and Jaya Manjunath

Featuring Dr Adam Friedman and Jaya M...
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist

From the Issue

Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Emma Guttman-Yassky, MD, PhD
Feature Story
Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod
10/10/2021
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical...
10/10/2021
The Dermatologist
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
NEA Approved Features
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
Quiz: Pain in Atopic Dermatitis
NEA Approved Features
Quiz: Pain in Atopic Dermatitis
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Get Eczema Wise During Eczema Awareness Month
Partner Approved
Get Eczema Wise During Eczema Awareness Month
10/16/2020
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
Feature Story
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
08/13/2020
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by...
08/13/2020
The Dermatologist
Feature Story
“Senile:” An Antiquated Descriptive Term
12/02/2024
Embracing a respectful approach to the aging process is essential for recognizing the rich tapestry of experiences that shape individuals over time.
Embracing a respectful approach to the aging process is essential for recognizing the rich tapestry of experiences that shape individuals over time.
Embracing a respectful approach...
12/02/2024
The Dermatologist
NEA Approved Features
What Constitutes a Flare? The Patient Perspective
12/02/2024
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care...
12/02/2024
The Dermatologist
Feature Story
Democratizing the Dermatology Residency Application Process: Is a Shelf Exam the Solution?
10/07/2024
The implementation of a dedicated shelf exam for dermatology can help standardize fourth-year rotations, leveling the playing field for students from less-prestigious medical schools and helping them demonstrate their enthusiasm for our...
The implementation of a dedicated shelf exam for dermatology can help standardize fourth-year rotations, leveling the playing field for students from less-prestigious medical schools and helping them demonstrate their enthusiasm for our...
The implementation of a...
10/07/2024
The Dermatologist
Feature Story
Broadening Definitions: What Constitutes a Natural or Organic Treatment?
09/06/2024
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural...
09/06/2024
The Dermatologist
NEA Approved Features
Mental Health Support for Patients With Atopic Dermatitis
09/06/2024
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health...
09/06/2024
The Dermatologist
Feature Story
Artificial Intelligence in Dermatology: Scribing and Documentation
08/05/2024
Have natural language processing and large language models matured enough to support implementation of artificial intelligence-assisted scribing in the right clinical setting?
Have natural language processing and large language models matured enough to support implementation of artificial intelligence-assisted scribing in the right clinical setting?
Have natural language processing...
08/05/2024
The Dermatologist
NEA Approved Features
The Impact of Atopic Dermatitis Symptoms on Mental Health
05/03/2024
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the...
05/03/2024
The Dermatologist
Feature Story
Artificial Intelligence in Dermatology: Cure or Curse?
03/06/2024
Ross Lane Pearlman, MD
Innovations like machine learning models will change everything. But not in the most obvious ways.
Innovations like machine learning models will change everything. But not in the most obvious ways.
Innovations like machine...
03/06/2024
The Dermatologist
Feature Story
An Analysis of Author and Content Characteristics of Hidradenitis Suppurativa Social Media Posts
12/05/2023
Social media platforms provide novel opportunities for physicians and patients to share health information, but the accuracy of posts must be vetted to avoid misinformation.
Social media platforms provide novel opportunities for physicians and patients to share health information, but the accuracy of posts must be vetted to avoid misinformation.
Social media platforms provide...
12/05/2023
The Dermatologist
NEA Approved Features
Atopic Dermatitis: Comorbidities and Treatment Challenges
12/05/2023
New research reveals a web of associated conditions and financial and access burdens, paving the way for a more comprehensive approach to patient care.
New research reveals a web of associated conditions and financial and access burdens, paving the way for a more comprehensive approach to patient care.
New research reveals a web of...
12/05/2023
The Dermatologist
Nov/Dec 2024 Cover

Current Issue

December 2024
Volume 32
Issue 8
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use